Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 1.31
-1.5 %
$ 20.3 M
Market Cap
-1.44
P/E
BALANCE SHEET
8.22 M
ASSETS
3.37 M
LIABILITIES
4.86 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
bioAffinity Technologies, Inc.
| Current Assets | 3.97 M |
| Cash & Short-Term Investments | 2.82 M |
| Receivables | 812 K |
| Other Current Assets | 340 K |
| Non-Current Assets | 4.25 M |
| Long-Term Investments | 0 |
| PP&E | 1.99 M |
| Other Non-Current Assets | 2.25 M |
| Current Liabilities | 2.25 M |
| Accounts Payable | 605 K |
| Short-Term Debt | 920 K |
| Other Current Liabilities | 723 K |
| Non-Current Liabilities | 1.12 M |
| Long-Term Debt | 1.12 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 2.8 | 11.4 | 1.4 | 83.1 K | 0.6 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0.8 | 10.5 K | 1.53 K | 1.53 K | 1.53 K |
| Inventory | 18.5 K | 5.54 K | 71.8 K | 28.4 K | 0 |
| Other Current Assets | 0.3 | 0.5 | 76.1 K | 34 K | 37.5 K |
| Total Current Assets | 4.0 | 12.0 | 1.4 | 0.1 | 0.6 |
| PP&E | 2.0 | 0.2 | 4.63 K | 9.45 K | 28.8 K |
| Intangible Assets | 0.8 | 0 | 0 | 0 | 0 |
| Goodwill | 1.4 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 16.1 K | 6 K | 10.4 K | 17.5 K | 12.5 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.2 | 12.2 | 1.5 | 0.1 | 0.7 |
| LIABILITIES | |||||
| Accounts Payable | 0.6 | 0.3 | 0.2 | 0.2 | 0.1 |
| Short Term Debt | 0.9 | 0.3 | 11.2 | 10.0 | 4.0 |
| Other Current Liabilities | 0.7 | 0.5 | 1.6 | 1.0 | 0.6 |
| Total Current Liabilities | 2.2 | 1.1 | 13.0 | 11.1 | 4.7 |
| Long Term Debt | 1.1 | 0 | 0.2 | 53.5 K | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 4.0 | 4.0 | 0 |
| Total Liabilities | 3.4 | 1.1 | 17.2 | 15.2 | 4.7 |
| EQUITY | |||||
| Common Stock | 65.8 K | 58.7 K | 18.7 K | 18.7 K | 18.7 K |
| Retained Earnings | (44.6) | (36.7) | (28.5) | (22.2) | (14.9) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (4.0) | (4.0) | 18.7 K |
| Total Equity | 4.9 | 11.0 | (15.8) | (15.1) | (4.0) |
| Total Liabilities and Equity | 8.2 | 12.2 | 1.5 | 0.1 | 0.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 8.7 | 4.5 | 7.4 | 7.4 | 7.4 |